laboratories

Health

AdminNovember 12, 2024
0 7

“Less than 3.5% of migraine patients who would benefit from monoclonal antibody treatment seek it.”
Health

AdminOctober 30, 2024
0 7

The study demonstrates the effectiveness of the adjuvanted RSV vaccine in people over 60 years of age.
Health

AdminOctober 27, 2024
0 12

Artificial intelligence and virtual reality are becoming the future in the treatment of post-stroke spasticity
Health

AdminOctober 25, 2024
0 12

Breast cancer is not one disease, but a very diverse clinicopathological entity.
Health

AdminAugust 26, 2024
0 26

EC approves Moderna RSV vaccine for people over 60
Business

AdminJuly 12, 2024
0 55

Moody’s Withdraws Grifols Ratings, Says Information to Support Them Insufficient and Inadequate | Companies
Business

AdminJuly 12, 2024
0 26

Moody’s Withdraws Grifols Ratings, Says Information to Support Them Insufficient and Inadequate | Companies
Health

AdminJune 23, 2024
0 138

Brexpiprazole, a new oral antipsychotic that improves positive, negative, and affective symptoms of schizophrenia.
Health

AdminJune 23, 2024
0 139

Messenger RNA changes approach to treatment
Health

AdminJune 22, 2024
0 124

First treatment in Spain for severe alopecia areata

Next page